CLINUVEL progresses vitiligo treatment program
09 mai 2022 21h33 HE
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, May 09, 2022 (GLOBE NEWSWIRE) -- A new potential therapy for the pigment loss disorder vitiligo will undergo further studies in North America this year. The drug afamelanotide...
Vitiligo Pipeline - Current Treatments, Drug Pipeline and Clinical Trial Outlook | Insights by DelveInsight
03 juin 2021 20h30 HE
|
DelveInsight Business Research LLP
Los Angeles, June 03, 2021 (GLOBE NEWSWIRE) -- Vitiligo Pipeline - Current Treatments, Drug Pipeline and Clinical Trial Outlook | Insights by DelveInsight Prominent companies such as Incyte...
Dermavant Announces First Patient Dosed in Phase 2a Clinical Trial of Topical Dual JAK/Syk Inhibitor Cerdulatinib for Vitiligo
03 déc. 2019 08h00 HE
|
Dermavant Sciences, Inc.
Phase 2a clinical trial for topical cerdulatinib to enroll 30 patients with vitiligoTop-line results anticipated in second half of 2020 BASEL, Switzerland and LONG BEACH, Calif., Dec. 03, 2019 ...
Dermatologists Share Skin Care Tips for People With Vitiligo
11 juin 2019 11h30 HE
|
American Academy of Dermatology
ROSEMONT, Ill., June 11, 2019 (GLOBE NEWSWIRE) -- Millions of people worldwide have vitiligo, a condition that causes the skin to lose its natural color, resulting in patches of light skin. Although...
Phase II study: SCENESSE® in combination with narrowband ultraviolet B (NB-UVB) achieves repigmentation in vitiligo
19 déc. 2018 06h38 HE
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia and SINGAPORE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- SUMMARY Phase II study in vitiligo, a treatment-resistant disease1n=21, patients of Asian ethnicity, darker skin...
American Academy of Dermatology Highlights Skin, Hair and Nail News at Annual Scientific Meeting
16 mars 2012 12h09 HE
|
American Academy of Dermatology
SAN DIEGO, CA--(Marketwire - Mar 16, 2012) - The American Academy of Dermatology (Academy) is holding its 70th Annual Meeting in San Diego, March 16-20, 2012, at the San Diego Convention Center....